You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窝轮》【瑞通认股证牛熊证】腾讯再迫近400元 即市资金捞Put 美团重回百元关 腾讯购19759 沽18193/ 美团牛59153 熊51507/ 阿里购18352 沽18353
阿思达克 02-06 10:52

市场憧憬武汉肺炎治疗有突破,道指隔晚收报29290点,升483点(或1.6%)。港府宣布今周六凌晨起内地入境人士包括港人需强制检疫14天,加上受内地股市上升带动,恒指昨收报26786点,升110点(或0.4%),连升三日。今早继续回升,涨近400点,曾迫近27200点,上试10天线阻力。恒指好仓(牛证及认购权证)昨净流出逾3500万港元(下同),恒指淡仓(熊证及认沽权证)同日净流入逾9700万元,反映投资者续看淡港股後市。昨日恒指牛证街货重货区为收回价26100至26199点,而熊证街货重货区为收回价27900至27999点。

纳指连日创收市新高,不过香港上市的大型科技股昨普遍先升後回。美团点评(03690)昨触及10天线(约102.7元)後反覆回落,收跌近1.5%,报99.5元,三连升走势告终,今早先跌後回升,曾跌穿99元,其後由即市低位最多反弹逾3%,再度挑战102元水平。昨分别有超过2300万元和逾1300万元净流入其好仓和淡仓。

腾讯(00700)是昨日北水经港股通净流入第二多的股份,全日录10.26亿元净流入。不过腾讯股价昨高见400元关口後受阻,午後更倒跌,一度跌穿390元,最终收报392.2元,微跌0.2%。今早续於400元关前徘徊。轮证资金流方面,昨有150万元净流出其好仓,淡仓同日则有逾1300万元净流入,今早即市续有资金捞认沽证望捕捉回吐。

传武汉肺炎治疗方案拟纳入药品阿比多尔,受批药企之一的石药(01093)昨在大成交下一度飙升11.8%至20.5元高位,其後大部分时间维持在20元关前争持,收市报19.16元,升4.4%,是表现最佳蓝筹。石药今早靠稳,最多升逾2%至19.6元,连升四日,其後升幅收窄。昨分别有逾970万元和20万元净流入其好仓和淡仓。

将於下周四公布业绩的阿里巴巴(09988),昨日股价上升1.1%,收报215.6元,不仅重上20天线,亦收复农历新年前的失地,连升三日。阿里今早略回,一度跌穿214元和20天线,其後靠稳。昨有逾1500万元净流出其好仓,淡仓同日则有逾1000万元净流入。

瑞通相关认股证之选择:

恒指贴价、短期购29693,行使价:28100点,2020年3月到期,实际杠杆:22.1倍

恒指轻微价外、短期沽11209,行使价:25000点,2020年3月到期,实际杠杆:18.1倍

美团贴价、中短期购13318,行使价:106.1元,2020年5月到期,实际杠杆:6.6倍

美团轻微价外、中短期沽21584,行使价:94.28元,2020年6月到期,实际杠杆:4.8倍

腾讯轻微价外、中短期购19759,行使价:431.48元,2020年7月到期,实际杠杆:8.4倍

腾讯轻微价外、中短期沽18193,行使价:360.2元,2020年6月到期,实际杠杆:8.5倍

石药轻微价外、中年期购11716,行使价:21.28元,2020年10月到期,实际杠杆:4.3倍

石药轻微价外、中短期沽12816,行使价:18元,2020年6月到期,实际杠杆:4.5倍

阿里轻微价外、中短期购18352,行使价:245.9元,2020年6月到期,实际杠杆:10.1倍

阿里轻微价外、中短期沽18353,行使价:199.8元,2020年7月到期,实际杠杆:7.2倍

中移贴价、中短期购13697,行使价:68.68元,2020年5月到期,实际杠杆:11倍

中移轻微价外、中短期沽18831,行使价:61.8元,2020年8月到期,实际杠杆:8.2倍

瑞通相关牛熊证之选择:

恒指牛证65572,收回价:26110点,杠杆比率:27.1倍

恒指熊证51766,收回价:27590点,杠杆比率:38.2倍

美团牛证59153,收回价:94.7元,杠杆比率:9.4倍

美团熊证51507,收回价:105.1元,杠杆比率:14.5倍

腾讯牛证68060,收回价:368.1元,杠杆比率:11.2倍

腾讯熊证50056,收回价:416.8元,杠杆比率:17.2倍

石药牛证63136,收回价:16.2元,杠杆比率:4.9倍

石药熊证61722,收回价:21.3元,杠杆比率:6.4倍重要风险通知

本结构性产品并无抵押品。

结构性产品之价格一般可急升亦可急跌,有可能损失结构性产品之全部或重大部分购买价,阁下对此应有所准备。

阁下投资前应了解产品风险,如有需要应谘询专业建议。~重要声明:

以上资讯由第三方提供,AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告,不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料,本公司亦不负品质保证之责任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account